AIRS Medical's SwiftMR® Achieves FDA Clearance
In a significant move for the medical imaging sector, AIRS Medical has announced that its innovative product,
SwiftMR®, has received FDA 510(k) clearance, enabling it to operate alongside Original Equipment Manufacturer (OEM) deep learning reconstruction solutions. This FDA approval positions
SwiftMR® as a vendor-neutral MRI image enhancement solution capable of significantly reducing scan times, thereby improving overall patient experience in imaging centers.
What is SwiftMR®?
SwiftMR® is a platform developed by AIRS Medical aimed at enhancing MRI image quality while reducing the time taken for scans by up to 50%. This technology is critical for both healthcare providers and patients, streamlining the imaging process across all vendors and equipment specifications. Currently, it is employed in more than 1,700 imaging centers and hospitals across over 40 countries, showcasing its global impact and acceptance in medical practice.
Functionality and Benefits
The functionality of
SwiftMR® extends to two primary operations with OEM deep learning (DL) solutions:
1.
Collaborative Acceleration: In scenarios where there is an existing OEM-DL solution installed, SwiftMR® integrates seamlessly with it. For example, in a case involving a GE 3T scanner and AIR Recon DL, SwiftMR® was able to reduce brain scan times further from 15 minutes to just 9 minutes. This integration not only makes the imaging process faster but also allows medical facilities to optimize their scheduling.
2.
Extensive Coverage: In instances where an OEM-DL solution does not cover specific sequences, SwiftMR® broadens the coverage range, facilitating AI-driven image enhancements. This capability is particularly beneficial as it enhances scan efficiency across all body parts and imaging protocols, thereby ensuring comprehensive functionality wherever needed.
As Jina Park, the Chief Strategy Officer at AIRS Medical, highlights, the variance between a 15-minute scan and a 10-minute scan can be pivotal for healthcare facilities aiming to transition patient scheduling from 30-minute slots to 20-minute slots. This potential for improved scheduling can have a significant impact on a facility's operational efficiency.
Quality Assurance and Testing
In the lead-up to this FDA approval, the AIRS Medical team ensured thorough testing of SwiftMR® with varied imaging vendors and magnetic field strengths. According to Woojin Jung, Head of Product at AIRS Medical, training the solution specifically on images processed through OEM-DL helped meet rigorous quality standards, instilling confidence amongst healthcare providers about utilizing SwiftMR® alongside existing OEM solutions.
Availability
Healthcare providers looking to improve their MRI scanning capabilities can now easily incorporate SwiftMR® into their operations. This will provide imaging centers with the desired faster scanning and reduced patient wait times, addressing a crucial area of concern in patient care. Interested parties can learn more and request demonstrations directly through the AIRS Medical website.
Conclusion
With the FDA clearance, AIRS Medical’s
SwiftMR® not only enhances the quality of MRI imaging but also redefines patient throughput in radiology departments. As the field of medical imaging continues to evolve with AI and advanced technologies, solutions like SwiftMR® pave the way for improved patient outcomes and operational efficiencies. For more details about SwiftMR® and its capabilities, visit
airsmed.com.